XML 21 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Cash, Cash Equivalents, and Marketable Securities

9 Months Ended

Sep. 30, 2024

Cash, Cash Equivalents, and Marketable Securities [Text Block]

Note 3. Cash, Cash Equivalents, and Marketable Securities

Available-for-Sale Securities

Available-for-sale securities as of September 30, 2024 were as follows:

	*September 30, 2024*
(in thousands)	*Amortized Cost*		*Gross Unrealized Gains*		*Gross Unrealized Losses*		*Fair Value*
Cash equivalents (contractual maturity within 90 days):
Money market funds	$	3,897	$	—	$	—	$	3,897
Total cash equivalents		3,897		—		—		3,897
Cash		10,748		—		—		10,748
Total cash and cash equivalents	$	14,645	$	—	$	—	$	14,645

Available-for-sale securities as of December 31, 2023 were as follows:

	*December 31, 2023*
(in thousands)	*Amortized Cost*		*Gross Unrealized Gains*		*Gross Unrealized Losses*		*Fair Value*
Cash equivalents (contractual maturity within 90 days):
U.S. Treasury securities	$	19,883	$	1	$	—	$	19,884
Money market funds		5,113		—		—		5,113
Total cash equivalents		24,996		1		—		24,997
Cash		3,824		—		—		3,824
Total cash and cash equivalents	$	28,820	$	1	$	—	$	28,821

Marketable securities (contractual maturity greater than 90 days but less than 1 year):
U.S. Treasury securities	$	6,179	$	—	$	—	$	6,179
Total marketable securities	$	6,179	$	—	$	—	$	6,179

We had no realized gains or losses from the sale of available-for-sale securities during the three and nine months ended September 30, 2024 and 2023. As of September 30, 2024 and December 31, 2023, we did not have any allowance for credit losses or impairments of available-for-sale securities.